Caricamento...
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Activation of the elongation factor 2 kinase (eEF2K) leads to the phosphorylation and inhibition of the elongation factor eEF2, reducing mRNA translation rates. Emerging evidence indicates that the regulation of factors involved in protein synthesis may be critical for controlling diverse biological...
Salvato in:
| Pubblicato in: | EMBO Rep |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5048377/ https://ncbi.nlm.nih.gov/pubmed/27572820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201642194 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|